DocMorris AG (SWX:DOCM)

Market Cap	775.00M +172.2%
Revenue (ttm)	1.18B +11.3%
Net Income	-125.94M
EPS	-2.61
Shares Out	50.49M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	169,139
Open	15.75
Previous Close	15.72
Day's Range	15.35 - 15.89
52-Week Range	3.92 - 16.58
Beta	1.78
Analysts	Hold
Price Target	12.41 (-19.15%)
Earnings Date	Mar 18, 2027

About DocMorris AG

DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. The company offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insurers, and health institutions. It sells its products to online mail-order pharmacies, and private individuals under the DocMorris, PromoFarma ...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1993
• Employees: 1,576
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: DOCM

Financial Performance

In 2025, DocMorris AG's revenue was 1.12 billion, an increase of 10.56% compared to the previous year's 1.02 billion. Losses were -134.40 million, 38.2% more than in 2024.

Analyst Summary

According to 8 analysts, the average rating for DOCM stock is "Hold." The 12-month stock price target is CHF 12.41, which is a decrease of -19.15% from the latest price.

Price Target

CHF 12.41

(-19.15% downside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 23, 2026

Data Sources Report a data error